Search

everythinglearnresearchcommunity

for

Search:↓

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Hairless mammals have genetic changes in both their protein-coding and regulatory sequences related to hair.

Higher BMI may increase the risk of psoriasis and some other skin diseases.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Blood stem cells are diverse, influenced by many factors, and understanding them is key for progress in regenerative medicine.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Low doses of Asiasari radix extract boost stem cell growth without changing their shape.

lncRNAs are important for understanding and treating skin diseases.

More research is needed to understand and manage rheumatoid arthritis better.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

HuR is essential for Treg function and preventing autoimmunity.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Pantethine may boost the immune system's ability to fight sarcoma.

Combining NB-UVB 311 nm therapy with standard treatment improves hair regrowth in children with alopecia areata and atopic dermatitis.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

New treatments for severe alopecia areata show promise but lack standard approval.

Fetal skin has unique immune cells different from adult skin.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

The document concludes that a complete skin restoration biomaterial does not yet exist, and more clinical trials are needed to ensure these therapies are safe and effective.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Tertiary lymphoid structures are important in immunotherapy and need more research.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

Tiny particles from 3D-grown skin cells speed up wound healing by promoting blood vessel growth.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.